Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT

Bone Marrow Transplant. 2008 Jul;42(1):67-9. doi: 10.1038/bmt.2008.79. Epub 2008 Mar 17.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • ABO Blood-Group System / immunology
  • Aged
  • Anemia, Hemolytic / drug therapy*
  • Anemia, Hemolytic / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • B-Lymphocytes / immunology*
  • Blood Group Incompatibility / immunology*
  • Blood Transfusion
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Leukemia, Myelomonocytic, Chronic / therapy
  • Rituximab
  • Syndrome
  • Transplantation, Homologous

Substances

  • ABO Blood-Group System
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab